Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
-
281
-
282
-
283
-
284
-
285
-
286
-
287
-
288
-
289
-
290
-
291
-
292
Decreased biomechanical stability of bones from <i>Col1a1-Krm2</i> transgenic mice.
Published 2013“…(D) Cortical thickness (C.Th.) and bone mineral density (vBMD) are decreased in <i>Col1a1-Krm2</i> transgenic mice compared to wildtype littermates. …”
-
293
-
294
-
295
-
296
-
297
Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice
Published 2011“…All bladders were voided of urine prior to weighing. Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
-
298
Decreased reactive gliosis following ES delivered 5d post-demyelination.
Published 2014“…Temporal analysis of LPC focal demyelination +/- ES as indicated in days post-LPC: 6d (D), 6d+ES (E), 8d (G), 8d+ES (H), 10d (J) 10d+ES or 12d (M) 12d+ES (N) post-LPC. Note: ES resulted in a significant decrease in the GFAP IF signal detected at 12d post-LPC (7 days post-ES; N) relative to 12d LPC only (M). …”
-
299
-
300